UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 583

Sortiert nach

Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia

Blood, 2009-04, Vol.113 (18), p.4403-4413

2009

Volltextzugriff (PDF)

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

Blood, 2009-09, Vol.114 (11), p.2273-2279

2009

Volltextzugriff (PDF)

The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo

Blood, 2010-11, Vol.116 (22), p.4578-4587

2010

Volltextzugriff (PDF)

ABT‐199 selectively inhibits BCL2 but not BCL2L1 and efficiently induces apoptosis of chronic lymphocytic leukaemic cells but not platelets

British journal of haematology, 2013-10, Vol.163 (1), p.139-142

2013

Volltextzugriff (PDF)

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

Leukemia, 2021-07, Vol.35 (7), p.2108-2113

2021

Volltextzugriff (PDF)

Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study

Haematologica (Roma), 2017-05, Vol.102 (5), p.903

2017

Volltextzugriff (PDF)

Voltage-gated proton channels maintain pH in human neutrophils during phagocytosis

Proceedings of the National Academy of Sciences - PNAS, 2009-10, Vol.106 (42), p.18022-18027

2009

Volltextzugriff (PDF)

Pooled analysis of safety data from clinical trials evaluating acalabrutinib monotherapy in mature B-cell malignancies

Leukemia, 2021-11, Vol.35 (11), p.3201-3211

2021

Volltextzugriff (PDF)

Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non–high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol

Blood, 2010-07, Vol.115 (26), p.5393-5397

2010

Volltextzugriff (PDF)

Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059)

Leukemia, 2020-05, Vol.34 (5), p.1458-1461

2020

Volltextzugriff (PDF)

Enhanced activation of an amino-terminally truncated isoform of the voltage-gated proton channel HVCN1 enriched in malignant B cells

Proceedings of the National Academy of Sciences - PNAS, 2014-12, Vol.111 (50), p.18078-18083

2014

Volltextzugriff (PDF)

Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells

The Journal of clinical investigation, 2009-05, Vol.119 (5), p.1109-1123

2009

Volltextzugriff (PDF)

Phase IA/II, multicentre, open‐label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non‐Hodgkin or Hodgkin lymphoma

British journal of haematology, 2014-01, Vol.164 (2), p.258-265

2014

Volltextzugriff (PDF)

Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia

British journal of haematology, 2013-08, Vol.162 (3), p.360-370

2013

Volltextzugriff (PDF)

Identification of a novel form of caspase-independent cell death triggered by BH3-mimetics in diffuse large B-cell lymphoma cell lines

Cell death & disease, 2024-04, Vol.15 (4), p.266-266, Article 266

2024

Volltextzugriff (PDF)

Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis

Leukemia, 2021-08, Vol.35 (8), p.2407-2411

2021

Volltextzugriff (PDF)

Efficacy of Vemurafenib in Hairy-Cell Leukemia

The New England journal of medicine, 2014-01, Vol.370 (3), p.286-288

2014

Volltextzugriff (PDF)

Breaking good: the inexorable rise of BTK inhibitors in the treatment of chronic lymphocytic leukaemia

British journal of haematology, 2014-07, Vol.166 (1), p.12-22

2014

Volltextzugriff (PDF)

Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features

Virchows Archiv : an international journal of pathology, 2021-07, Vol.479 (1), p.133-145

2021

Volltextzugriff (PDF)

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B‐cell lymphoma

American journal of hematology, 2016-09, Vol.91 (9), p.923-930

2016

Volltextzugriff (PDF)

Hsp72 and Nek6 Cooperate to Cluster Amplified Centrosomes in Cancer Cells

Cancer research (Chicago, Ill.), 2017-09, Vol.77 (18), p.4785-4796

2017

Volltextzugriff (PDF)

1 – 25 von 583

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(539)
Mit Volltextzugriff
(499)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(583)
Japanisch
(64)

Erscheinungsjahr

n.n

Thema

Science & Technology
(394)
Life Sciences & Biomedicine
(328)
Humans
(315)
Female
(148)
Biological And Medical Sciences
(147)
Male
(143)
Medical Sciences
(132)
Hematology
(131)
Middle Aged
(121)
Adult
(105)
Aged
(84)
Hematologic And Hematopoietic Diseases
(73)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(67)
Animals
(53)
Oncology
(53)
Physical Sciences
(47)
Aged, 80 And Over
(41)
Leukemia
(33)
Adolescent
(31)
Genetics & Heredity
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia

Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo

ABT‐199 selectively inhibits BCL2 but not BCL2L1 and efficiently induces apoptosis of chronic lymphocytic leukaemic cells but not platelets

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study

Voltage-gated proton channels maintain pH in human neutrophils during phagocytosis

Pooled analysis of safety data from clinical trials evaluating acalabrutinib monotherapy in mature B-cell malignancies

Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non–high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol

Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059)

Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia

A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia

Enhanced activation of an amino-terminally truncated isoform of the voltage-gated proton channel HVCN1 enriched in malignant B cells

Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells

Phase IA/II, multicentre, open‐label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non‐Hodgkin or Hodgkin lymphoma

Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia

Identification of a novel form of caspase-independent cell death triggered by BH3-mimetics in diffuse large B-cell lymphoma cell lines

Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis

A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms

Efficacy of Vemurafenib in Hairy-Cell Leukemia

Breaking good: the inexorable rise of BTK inhibitors in the treatment of chronic lymphocytic leukaemia

Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B‐cell lymphoma

Hsp72 and Nek6 Cooperate to Cluster Amplified Centrosomes in Cancer Cells

Suchergebnisse filtern